Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Mechanistic targets and phytochemical strategies for breaking the obesity-cancer link.

Ford NA, Lashinger LM, Allott EH, Hursting SD.

Front Oncol. 2013 Aug 19;3:209. doi: 10.3389/fonc.2013.00209. eCollection 2013.

2.

Obesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvironmental) issue.

Hursting SD, Dunlap SM.

Ann N Y Acad Sci. 2012 Oct;1271:82-7. doi: 10.1111/j.1749-6632.2012.06737.x. Review.

3.

Obesity, Diabetes and Cancer: A Mechanistic Perspective.

Cifarelli V, Hursting SD.

Int J Diabetol Vasc Dis Res. 2015;2015(Suppl 4). doi: 10.19070/2328-353X-SI04001. Epub 2015 Sep 28.

4.

Obesity, energy balance, and cancer: a mechanistic perspective.

Hursting SD.

Cancer Treat Res. 2014;159:21-33. doi: 10.1007/978-3-642-38007-5_2. Review.

PMID:
24114472
5.

Growth signals, inflammation, and vascular perturbations: mechanistic links between obesity, metabolic syndrome, and cancer.

Hursting SD, Hursting MJ.

Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1766-70. doi: 10.1161/ATVBAHA.111.241927. Review.

6.

The growing challenge of obesity and cancer: an inflammatory issue.

Harvey AE, Lashinger LM, Hursting SD.

Ann N Y Acad Sci. 2011 Jul;1229:45-52. doi: 10.1111/j.1749-6632.2011.06096.x. Review.

PMID:
21793838
7.

Reducing the weight of cancer: mechanistic targets for breaking the obesity-carcinogenesis link.

Hursting SD, Lashinger LM, Wheatley KW, Rogers CJ, Colbert LH, Nunez NP, Perkins SN.

Best Pract Res Clin Endocrinol Metab. 2008 Aug;22(4):659-69. doi: 10.1016/j.beem.2008.08.009. Review.

PMID:
18971125
8.

Calorie restriction and cancer prevention: a mechanistic perspective.

Hursting SD, Dunlap SM, Ford NA, Hursting MJ, Lashinger LM.

Cancer Metab. 2013 Mar 7;1(1):10. doi: 10.1186/2049-3002-1-10.

9.

Interacting inflammatory and growth factor signals underlie the obesity-cancer link.

Lashinger LM, Ford NA, Hursting SD.

J Nutr. 2014 Feb;144(2):109-13. doi: 10.3945/jn.113.178533. Epub 2013 Nov 27. Review.

10.

Energy balance and carcinogenesis: underlying pathways and targets for intervention.

Hursting SD, Lashinger LM, Colbert LH, Rogers CJ, Wheatley KW, Nunez NP, Mahabir S, Barrett JC, Forman MR, Perkins SN.

Curr Cancer Drug Targets. 2007 Aug;7(5):484-91. Review.

PMID:
17691908
11.

Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research.

Hursting SD, Smith SM, Lashinger LM, Harvey AE, Perkins SN.

Carcinogenesis. 2010 Jan;31(1):83-9. doi: 10.1093/carcin/bgp280. Epub 2009 Dec 7. Review.

PMID:
19969554
12.

Physical activity and cancer prevention : pathways and targets for intervention.

Rogers CJ, Colbert LH, Greiner JW, Perkins SN, Hursting SD.

Sports Med. 2008;38(4):271-96. Review.

PMID:
18348589
13.

Energy balance, physical activity, and cancer risk.

Fair AM, Montgomery K.

Methods Mol Biol. 2009;472:57-88. doi: 10.1007/978-1-60327-492-0_3. Review.

PMID:
19107429
14.

The enhancing effects of obesity on mammary tumor growth and Akt/mTOR pathway activation persist after weight loss and are reversed by RAD001.

De Angel RE, Conti CJ, Wheatley KE, Brenner AJ, Otto G, Degraffenried LA, Hursting SD.

Mol Carcinog. 2013 Jun;52(6):446-58. doi: 10.1002/mc.21878. Epub 2012 Jan 30.

PMID:
22290600
15.

Obesity, metabolism and the microenvironment: Links to cancer.

Sundaram S, Johnson AR, Makowski L.

J Carcinog. 2013 Oct 9;12:19. doi: 10.4103/1477-3163.119606. Review.

16.

The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.

Antwi F, Fazylova N, Garcon MC, Lopez L, Rubiano R, Slyer JT.

JBI Libr Syst Rev. 2012;10(42 Suppl):1-14.

PMID:
27820152
17.

Obesity and resistance to cancer chemotherapy: interacting roles of inflammation and metabolic dysregulation.

Lashinger LM, Rossi EL, Hursting SD.

Clin Pharmacol Ther. 2014 Oct;96(4):458-63. doi: 10.1038/clpt.2014.136. Epub 2014 Jun 24. Review.

PMID:
24960521
18.

Dietary energy balance modulation of Kras- and Ink4a/Arf+/--driven pancreatic cancer: the role of insulin-like growth factor-I.

Lashinger LM, Harrison LM, Rasmussen AJ, Logsdon CD, Fischer SM, McArthur MJ, Hursting SD.

Cancer Prev Res (Phila). 2013 Oct;6(10):1046-55. doi: 10.1158/1940-6207.CAPR-13-0185. Epub 2013 Aug 26.

19.

Obesity, independent of p53 gene dosage, promotes mammary tumor progression and upregulates the p53 regulator microRNA-504.

Ford NA, Dunlap SM, Wheatley KE, Hursting SD.

PLoS One. 2013 Jun 28;8(6):e68089. doi: 10.1371/journal.pone.0068089. Print 2013.

20.

Dietary energy balance modulates signaling through the Akt/mammalian target of rapamycin pathways in multiple epithelial tissues.

Moore T, Beltran L, Carbajal S, Strom S, Traag J, Hursting SD, DiGiovanni J.

Cancer Prev Res (Phila). 2008 Jun;1(1):65-76. doi: 10.1158/1940-6207.CAPR-08-0022. Epub 2008 Mar 31. Erratum in: Cancer Prev Res (Phila Pa). 2009 Nov;2(11):999.

Supplemental Content

Support Center